Medical Devices Investors & VC Firms in San Diego
13 firms in this list, with a median first check of $100K. 6 of them lead rounds. Generated from verified public data and updated continuously.
Red Tree Venture
San DiegoSeed–Series B
27 people
Kaleida Capital
San Diego
14 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
FusionX Ventures
San DiegoSeed–Series A
8 people
NuFund Venture Group
San DiegoSeed–Growth$1M
7 people
Torrey Pines Investment
San DiegoSeed–Series A
7 people
City Hill Ventures
San DiegoSeed–Series A$100K – $20M
1 person
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
Correlation Ventures
San FranciscoPre-Seed–Series A$100K – $4M
19 people
Alexandria
PasadenaSeed–Series B
41 people
Avalon BioVentures
La JollaPre-Seed–Seed
18 people
Ventac Partners
Gentofte
12 people
MESA VERDE VENTURE PARTNERS
La JollaSeed–Series A
8 people
Frequently asked questions
- Who are the top medical devices investors & vc firms in san diego?
- Top medical devices investors & vc firms in san diego include Red Tree Venture, Kaleida Capital, Shepherd Ventures, FusionX Ventures, NuFund Venture Group, Torrey Pines Investment, City Hill Ventures, Boxer Capital, LLC — 13 firms in total meet the criteria.
- What is the typical first check among medical devices investors & vc firms in san diego?
- The median first check among the 13 medical devices investors & vc firms in san diego tracked here is $100K.
- How many medical devices investors & vc firms in san diego lead rounds?
- 6 of the 13 medical devices investors & vc firms in san diego tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.












































